Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |